Patents by Inventor Erwin Waldvogel

Erwin Waldvogel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220177417
    Abstract: The present invention relates to a new process for the production of substituted 2-[2-(phenyl) ethylaminojalkaneamide derivatives of the following formula (I), in particular 2-[2-(3-butoxyphenyl)-ethylamino]-N,N-dimethylacetamide in high yields with very high chemical purity.
    Type: Application
    Filed: April 8, 2020
    Publication date: June 9, 2022
    Applicant: Newron Pharmaceuticals S.p.A.
    Inventors: Wolfgang Skranc, Michael Wolberg, Matthias Riepl, Christoph Imboden, Erwin Waldvogel
  • Patent number: 9856207
    Abstract: The invention relates to a new process for the production and/or purification of the salt of the compound (S)-2-[4-(2-fluorobenzyloxy) benzylamino]propanamide, i.e. ralfinamide, or the respective R-enantiomer, with methane sulfonic acid in high yields and very high enantiomeric and chemical purity in the form of the crystalline anhydrous polymorph identified as form A, wherein said salt is substantially free from impurities having genotoxic effect, such as (C1-C5)alkanylmethanesulfonates, and residual solvents known as potential precursors thereof, such as (C1-C5)alkanols or esters thereof with lower alkanoic acids.
    Type: Grant
    Filed: October 12, 2016
    Date of Patent: January 2, 2018
    Assignee: NEWRON PHARMACEUTICALS S.P.A.
    Inventors: Claudio Giordano, Erwin Waldvogel
  • Publication number: 20170029365
    Abstract: The invention relates to a new process for the production and/or purification of the salt of the compound (S)-2-[4-(2-fluorobenzyloxy) benzylamino]propanamide, i.e. ralfinamide, or the respective R-enantiomer, with methane sulfonic acid in high yields and very high enantiomeric and chemical purity in the form of the crystalline anhydrous polymorph identified as form A, wherein said salt is substantially free from impurities having genotoxic effect, such as (C1-C5)alkanylmethanesulfonates, and residual solvents known as potential precursors thereof, such as (C1-C5)alkanols or esters thereof with lower alkanoic acids.
    Type: Application
    Filed: October 12, 2016
    Publication date: February 2, 2017
    Inventors: Claudio Giordano, Erwin Waldvogel
  • Patent number: 9505708
    Abstract: The invention relates to a new process for the production and/or purification of the salt of the compound (S)-2-[4-(2-fluorobenzyloxy) benzylamino]propanamide, i.e. ralfinamide, or the respective R-enantiomer, with methane sulfonic acid in high yields and very high enantiomeric and chemical purity in the form of the crystalline anhydrous polymorph identified as form A, wherein said salt is substantially free from impurities having genotoxic effect, such as (C1-C5)alkanylmethanesulfonates, and residual solvents known as potential precursors thereof, such as (C1-C5)alkanols or esters thereof with lower alkanoic acids.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: November 29, 2016
    Assignee: NEWRON PHARMACEUTICALS S.P.A.
    Inventors: Claudio Giordano, Erwin Waldvogel
  • Publication number: 20130039983
    Abstract: The invention relates to a new process for the production and/or purification of the salt of the compound (S)-2-[4-(2-fluorobenzyloxy)benzylamino]propanamide, i.e. ralfinamide, or the respective R-enantiomer, with methanesulfonic acid in high yields and very high enantiomeric and chemical purity in the form of the crystalline anhydrous polymorph identified as form A, wherein said salt is substantially free from impurities having genotoxic effect, such as (C1-C5)alkanylmethanesulfonates, and residual solvents known as potential precursors thereof, such as (C1-C5)alkanols or esters thereof with lower alkanoic acids.
    Type: Application
    Filed: April 6, 2011
    Publication date: February 14, 2013
    Applicant: NEWRON PHARMACEUTICALS S.P.A.
    Inventors: Claudio Giordano, Erwin Waldvogel
  • Patent number: 5811569
    Abstract: The invention discloses a novel process for the preparation of a compound of formula II ##STR1## wherein R.sub.1 is C.sub.1-5 alkyl,R.sub.2 is hydrogen or C.sub.1-5 alkyl, andR.sub.3 is optionally substituted phenyl,comprising the reaction of a 4-hydroxypyrazole of formula III ##STR2## wherein R.sub.1 and R.sub.2 are as defined for formula II, with a benzylhalide of formula IVHal--CH.sub.2 --R.sub.3 (IV)wherein Hal is halogen, preferably bromine or chlorine, and R.sub.3 is as defined for formula II, in the presence of a base. The invention further comprises a novel process for the preparation of the 4-hydroxypyrazole of formula III. The compounds of formulae II and III are intermediates for highly effective systemic fungicides of the class of pyrazolyl acetic acid derivatives.
    Type: Grant
    Filed: November 1, 1996
    Date of Patent: September 22, 1998
    Assignee: Sandoz Ltd
    Inventors: Erwin Waldvogel, Eugen Eichenberger
  • Patent number: 5670648
    Abstract: The invention discloses a novel process for the preparation of a compound of formula II ##STR1## wherein R.sub.1 is C.sub.1-5 alkyl,R.sub.2 is hydrogen or C.sub.1-5 alkyl, andR.sub.3 is optionally substituted phenyl,comprising the reaction of a 4-hydroxypyrazole of formula III ##STR2## wherein R.sub.1 and R.sub.2 are as defined for formula II, with a benzylhalide of formula IVHal--CH.sub.2 --R.sub.3 (IV)wherein Hal is halogen, preferably bromine or chlorine, and R.sub.3 is as defined for formula II, in the presence of a base. The invention further comprises a novel process for the preparation of the 4-hydroxypyrazole of formula III. The compounds of formulae II and III are intermediates for highly effective systemic fungicides of the class of pyrazolyl acetic acid derivatives.
    Type: Grant
    Filed: November 1, 1996
    Date of Patent: September 23, 1997
    Assignee: Sandoz Ltd.
    Inventors: Erwin Waldvogel, Eugen Eichenberger
  • Patent number: 4273780
    Abstract: The present invention provides anti-9,10-dihydro-4-(1-methyl-4-piperidylidene)-4H-benzo[4,5]-cyclohepta[1 ,2-b]thiophen-10(9H)-one oxime of formula ##STR1## useful for the treatment of allergic conditions.
    Type: Grant
    Filed: January 8, 1980
    Date of Patent: June 16, 1981
    Assignee: Sandoz Ltd.
    Inventors: Erwin Waldvogel, Jean-Michel Bastian, Gustav Schwarb
  • Patent number: 4128549
    Abstract: The present invention concerns a novel process for the production of known benzocycloheptathiophene derivatives of the formula: ##STR1## wherein R.sub.1 is hydrogen, chlorine, bromine or alkoxy, and R.sub.2 is alkyl. The compounds are useful as specific histaminolytics for use in the treatment of allergic conditions.
    Type: Grant
    Filed: February 3, 1977
    Date of Patent: December 5, 1978
    Assignee: Sandoz Ltd.
    Inventors: Jean-Pierre Bourquin, Gustav Schwarb, Erwin Waldvogel
  • Patent number: 4107434
    Abstract: Novel process for the production of antibacterially active pleuromutilin derivatives.
    Type: Grant
    Filed: January 10, 1977
    Date of Patent: August 15, 1978
    Assignee: Sandoz Ltd.
    Inventor: Erwin Waldvogel
  • Patent number: 3960894
    Abstract: The present invention concerns a novel process for the production of known benzocycloheptathiophene derivatives of the formula: ##SPC1##Wherein R.sub.1 is hydrogen, chlorine, bromine or alkoxy, and R.sub.2 is alkyl. The compounds are useful as specific histaminolytics for use in the treatment of allergic conditions.
    Type: Grant
    Filed: July 26, 1974
    Date of Patent: June 1, 1976
    Assignee: Sandoz Ltd.
    Inventors: Jean-Pierre Bourquin, Gustav Schwarb, Erwin Waldvogel